NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Employees - 21,
CEO - Mr. Brian Carrico,
Sector - Healthcare,
Country - US,
Market Cap - 28.81M
Altman ZScore(max is 10): -30.85, Piotroski Score(max is 10): 2, Working Capital: $439823, Total Assets: $3029809, Retained Earnings: $-59078296, EBIT: -7608081, Total Liabilities: $2771330, Revenue: $2934945
AryaFin Target Price - $-1.73 - Current Price $3.99 - Analyst Target Price $4.75
| Ticker | NRXS |
| Index | - |
| Curent Price | 3.99 |
| Change | 75.77% |
| Market Cap | 28.81M |
| Average Volume | 28.21K |
| Income | -8.82M |
| Sales | 2.93M |
| Book Value/Share | 0.04 |
| Cash/Share | 0.28 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 21 |
| Moving Avg 20days | 69.72% |
| Moving Avg 50days | 86.35% |
| Moving Avg 200days | 52.34% |
| Shares Outstanding | 7.22M |
| Earnings Date | May 12 BMO |
| Inst. Ownership | 13.64% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 9.83 |
| Price/Book | 113.26 |
| Price/Cash | 14.33 |
| Price/FCF | - |
| Quick Ratio | 1.19 |
| Current Ratio | 1.21 |
| Debt/Equity | 1.50 |
| Return on Assets | -422.56% |
| Return on Equity | -2480.49% |
| Return on Investment | -1775.49% |
| Gross Margin | 85.86% |
| Ops Margin | -259.62% |
| Profit Margin | -300.66% |
| RSI | 79.57 |
| BETA(β) | 2.95 |
| From 52week Low | 200.00% |
| From 52week High | 5.56% |
| EPS | -1.24 |
| EPS next Year | -0.51 |
| EPS next Qtr | -0.23 |
| EPS this Year | 14.75% |
| EPS next 5 Year | - |
| EPS past 5 Year | -14.82% |
| Sales past 5 Year | 10.11% |
| EPS Y/Y | 62.82% |
| Sales Y/Y | 27.52% |
| EPS Q/Q | -3.15% |
| Sales Q/Q | 38.51% |
| Sales Surprise | 23.54% |
| EPS Surprise | -37.50% |
| ATR(14) | 0.54 |
| Perf Week | 73.48% |
| Perf Month | 122.28% |
| Perf Quarter | 72.73% |
| Perf Year | 41.49% |
| Perf YTD | 69.79% |
| Target Price | 4.75 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer